{"id":1622,"date":"2022-11-30T21:45:30","date_gmt":"2022-11-30T21:45:30","guid":{"rendered":"https:\/\/ifpma.flywheelsites.com\/?post_type=experts&#038;p=1622"},"modified":"2025-03-25T12:18:21","modified_gmt":"2025-03-25T11:18:21","slug":"james-anderson","status":"publish","type":"experts","link":"https:\/\/www.ifpma.org\/experts\/james-anderson\/","title":{"rendered":"James Anderson"},"content":{"rendered":"<p><strong>James leads IFPMA\u2019s work spanning global health, including the innovative pharmaceutical industry\u2019s policy on pandemic preparedness, antimicrobial resistance (AMR), and global access to medicines and vaccines. <\/strong><\/p>\n<p>In his previous role as Head of Corporate Government Affairs at GlaxoSmithKline (GSK), James was responsible for GSK\u2019s strategic engagement with the UK Government. He also held positions in Government Affairs and Commercial at European and global levels and led their strategy and engagement on AMR.<\/p>\n<p>He was in the founding team of the AMR Action Fund and led the development of the 2016 Davos Declaration on AMR and the subsequent United Nations General Assembly Industry AMR Roadmap. He has advised on AMR policy development at the WHO, UN, EU Commission, and with national governments.<\/p>\n<p>James is Chair of the AMR Industry Alliance Board and Chair of the INTREPID Alliance Board. He has also served as the Vice-Chair of Health at Business at the OECD, and as a member of the UK Life Science Strategy Board.<\/p>\n<p>He has an MBA in Business from Harvard Business School as well as a Masters in Natural Sciences-Molecular and Genetic Pathology from Cambridge University.<\/p>\n","protected":false},"featured_media":2330,"parent":0,"menu_order":13,"template":"","expert_type":[51],"class_list":["post-1622","experts","type-experts","status-publish","has-post-thumbnail","hentry","expert_type-global-health-and-access"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>James Anderson | IFPMA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ifpma.org\/experts\/james-anderson\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"James Anderson | IFPMA\" \/>\n<meta property=\"og:description\" content=\"James leads IFPMA\u2019s work spanning global health, including the innovative pharmaceutical industry\u2019s policy on pandemic preparedness, antimicrobial resistance (AMR), and global access to medicines and vaccines. In his previous role as Head of Corporate Government Affairs at GlaxoSmithKline (GSK), James was responsible for GSK\u2019s strategic engagement with the UK Government. He also held positions in...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ifpma.org\/experts\/james-anderson\/\" \/>\n<meta property=\"og:site_name\" content=\"IFPMA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/IFPMA\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-25T11:18:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/12\/expert-james-anderson-v2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1300\" \/>\n\t<meta property=\"og:image:height\" content=\"820\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@IFPMA\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ifpma.org\/experts\/james-anderson\/\",\"url\":\"https:\/\/www.ifpma.org\/experts\/james-anderson\/\",\"name\":\"James Anderson | IFPMA\",\"isPartOf\":{\"@id\":\"https:\/\/www.ifpma.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ifpma.org\/experts\/james-anderson\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ifpma.org\/experts\/james-anderson\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/12\/expert-james-anderson-v2.jpg\",\"datePublished\":\"2022-11-30T21:45:30+00:00\",\"dateModified\":\"2025-03-25T11:18:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ifpma.org\/experts\/james-anderson\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ifpma.org\/experts\/james-anderson\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ifpma.org\/experts\/james-anderson\/#primaryimage\",\"url\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/12\/expert-james-anderson-v2.jpg\",\"contentUrl\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/12\/expert-james-anderson-v2.jpg\",\"width\":1300,\"height\":820},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ifpma.org\/experts\/james-anderson\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ifpma.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"James Anderson\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ifpma.org\/#website\",\"url\":\"https:\/\/www.ifpma.org\/\",\"name\":\"IFPMA\",\"description\":\"Innovating to improve health worldwide\",\"publisher\":{\"@id\":\"https:\/\/www.ifpma.org\/#organization\"},\"alternateName\":\"International Federation of Pharmaceutical Manufacturers and Associations\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ifpma.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ifpma.org\/#organization\",\"name\":\"IFPMA\",\"alternateName\":\"International Federation of Pharmaceutical Manufacturers and Associations\",\"url\":\"https:\/\/www.ifpma.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ifpma.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-landscape-narrow.png\",\"contentUrl\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-landscape-narrow.png\",\"width\":1379,\"height\":733,\"caption\":\"IFPMA\"},\"image\":{\"@id\":\"https:\/\/www.ifpma.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/IFPMA\/\",\"https:\/\/x.com\/IFPMA\",\"https:\/\/www.linkedin.com\/company\/ifpma\/\",\"https:\/\/www.youtube.com\/user\/ifpma\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"James Anderson | IFPMA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ifpma.org\/experts\/james-anderson\/","og_locale":"en_US","og_type":"article","og_title":"James Anderson | IFPMA","og_description":"James leads IFPMA\u2019s work spanning global health, including the innovative pharmaceutical industry\u2019s policy on pandemic preparedness, antimicrobial resistance (AMR), and global access to medicines and vaccines. In his previous role as Head of Corporate Government Affairs at GlaxoSmithKline (GSK), James was responsible for GSK\u2019s strategic engagement with the UK Government. He also held positions in...","og_url":"https:\/\/www.ifpma.org\/experts\/james-anderson\/","og_site_name":"IFPMA","article_publisher":"https:\/\/www.facebook.com\/IFPMA\/","article_modified_time":"2025-03-25T11:18:21+00:00","og_image":[{"width":1300,"height":820,"url":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/12\/expert-james-anderson-v2.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@IFPMA","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ifpma.org\/experts\/james-anderson\/","url":"https:\/\/www.ifpma.org\/experts\/james-anderson\/","name":"James Anderson | IFPMA","isPartOf":{"@id":"https:\/\/www.ifpma.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ifpma.org\/experts\/james-anderson\/#primaryimage"},"image":{"@id":"https:\/\/www.ifpma.org\/experts\/james-anderson\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/12\/expert-james-anderson-v2.jpg","datePublished":"2022-11-30T21:45:30+00:00","dateModified":"2025-03-25T11:18:21+00:00","breadcrumb":{"@id":"https:\/\/www.ifpma.org\/experts\/james-anderson\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ifpma.org\/experts\/james-anderson\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ifpma.org\/experts\/james-anderson\/#primaryimage","url":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/12\/expert-james-anderson-v2.jpg","contentUrl":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/12\/expert-james-anderson-v2.jpg","width":1300,"height":820},{"@type":"BreadcrumbList","@id":"https:\/\/www.ifpma.org\/experts\/james-anderson\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ifpma.org\/"},{"@type":"ListItem","position":2,"name":"James Anderson"}]},{"@type":"WebSite","@id":"https:\/\/www.ifpma.org\/#website","url":"https:\/\/www.ifpma.org\/","name":"IFPMA","description":"Innovating to improve health worldwide","publisher":{"@id":"https:\/\/www.ifpma.org\/#organization"},"alternateName":"International Federation of Pharmaceutical Manufacturers and Associations","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ifpma.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ifpma.org\/#organization","name":"IFPMA","alternateName":"International Federation of Pharmaceutical Manufacturers and Associations","url":"https:\/\/www.ifpma.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ifpma.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-landscape-narrow.png","contentUrl":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-landscape-narrow.png","width":1379,"height":733,"caption":"IFPMA"},"image":{"@id":"https:\/\/www.ifpma.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/IFPMA\/","https:\/\/x.com\/IFPMA","https:\/\/www.linkedin.com\/company\/ifpma\/","https:\/\/www.youtube.com\/user\/ifpma"]}]}},"_links":{"self":[{"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/experts\/1622","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/experts"}],"about":[{"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/types\/experts"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/media\/2330"}],"wp:attachment":[{"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/media?parent=1622"}],"wp:term":[{"taxonomy":"expert_type","embeddable":true,"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/expert_type?post=1622"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}